{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:44:45Z","timestamp":1792201485791,"version":"4.4.0"},"publisher-location":"Cham","reference-count":255,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032091321","type":"print"},{"value":"9783032091338","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/7854_2025_597","type":"book-chapter","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T18:02:54Z","timestamp":1753380174000},"page":"209-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ageing, Neurodegeneration and the Endocannabinoid System"],"prefix":"10.1007","author":[{"given":"Javier","family":"Fern\u00e1ndez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onintza","family":"Sagredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"G\u00f3mez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"de Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"597_CR1","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1096\/fj.05-3995fje","volume":"19","author":"T Aguado","year":"2005","unstructured":"Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B et al (2005) The endocannabinoid system drives neural progenitor proliferation. FASEB J 19:1704\u20131706","journal-title":"FASEB J"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1523\/JNEUROSCI.3101-05.2006","volume":"26","author":"T Aguado","year":"2006","unstructured":"Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B et al (2006) The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 26:1551\u20131561","journal-title":"J Neurosci"},{"key":"597_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2022.102210","volume":"128","author":"L Aguilar-Hern\u00e1ndez","year":"2023","unstructured":"Aguilar-Hern\u00e1ndez L, Alejandre R, C\u00e9sar Morales-Medina J, Iannitti T, Flores G (2023) Cellular mechanisms in brain aging: focus on physiological and pathological aging. J Chem Neuroanat 128:102210","journal-title":"J Chem Neuroanat"},{"key":"597_CR4","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.1073\/pnas.1016442108","volume":"108","author":"O Albayram","year":"2011","unstructured":"Albayram O, Alferink J, Pitsch J, Piyanova A, Neitzert K, Poppensieker K et al (2011) Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. Proc Natl Acad Sci USA 108:11256\u201311261","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/sj.bjp.0707466","volume":"153","author":"A Ar\u00e9valo-Mart\u00edn","year":"2008","unstructured":"Ar\u00e9valo-Mart\u00edn A, Garc\u00eda-Ovejero D, G\u00f3mez O, Rubio-Araiz A, Navarro-Galve B, Guaza C et al (2008) CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. Br J Pharmacol 153:216\u2013225","journal-title":"Br J Pharmacol"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1471-4159.2007.05149.x","volume":"105","author":"E Aso","year":"2008","unstructured":"Aso E, Ozaita A, Valdiz\u00e1n EM, Ledent C, Pazos A, Maldonado R, Valverde O (2008) BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem 105:565\u2013572","journal-title":"J Neurochem"},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fnins.2016.00243","volume":"10","author":"E Aso","year":"2016","unstructured":"Aso E, Ferrer I (2016) CB2 cannabinoid receptor as potential target against Alzheimer\u2019s disease. Front Neurosci 10:243","journal-title":"Front Neurosci"},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","volume":"11","author":"D Athauda","year":"2015","unstructured":"Athauda D, Foltynie T (2015) The ongoing pursuit of neuroprotective therapies in Parkinson\u2019s disease. Nat Rev Neurol 11:25\u201340","journal-title":"Nat Rev Neurol"},{"key":"597_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lfs.2014.12.016","volume":"138","author":"F Ativie","year":"2015","unstructured":"Ativie F, Albayram O, Bach K, Pradier B, Zimmer A, Bilkei-Gorzo A (2015) Enhanced microglial activity in FAAH(\u2212\/\u2212) animals. Life Sci 138:52\u201356","journal-title":"Life Sci"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1021\/acschemneuro.7b00508","volume":"9","author":"SM Augustin","year":"2018","unstructured":"Augustin SM, Lovinger DM (2018) Functional relevance of endocannabinoid-dependent synaptic plasticity in the central nervous system. ACS Chem Neurosci 9:2146\u20132161","journal-title":"ACS Chem Neurosci"},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bcp.2018.08.016","volume":"157","author":"MS Aymerich","year":"2018","unstructured":"Aymerich MS, Aso E, Abellanas MA, Tolon RM, Ramos JA, Ferrer I et al (2018) Cannabinoid pharmacology\/therapeutics in chronic degenerative disorders affecting the central nervous system. Biochem Pharmacol 157:67\u201384","journal-title":"Biochem Pharmacol"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.bjp.0707593","volume":"153","author":"I Bab","year":"2008","unstructured":"Bab I, Zimmer A (2008) Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 153:182\u2013188","journal-title":"Br J Pharmacol"},{"key":"597_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12035-011-8164-6","volume":"43","author":"D Bano","year":"2011","unstructured":"Bano D, Agostini M, Melino G, Nicotera P (2011) Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect. Mol Neurobiol 43:124\u2013130","journal-title":"Mol Neurobiol"},{"key":"597_CR14","first-page":"2986","volume":"10","author":"MS Basile","year":"2022","unstructured":"Basile MS, Mazzon E (2022) The role of cannabinoid type 2 receptors in Parkinson\u2019s disease. Biomedicine 10:2986","journal-title":"Biomedicine"},{"key":"597_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/YCO.0000000000000140","volume":"28","author":"BT Baune","year":"2015","unstructured":"Baune BT (2015) Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention? Curr Opin Psychiatry 28:148\u2013154","journal-title":"Curr Opin Psychiatry"},{"key":"597_CR16","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","volume":"23","author":"C Benito","year":"2003","unstructured":"Benito C, Nu\u00f1ez E, Tolon RM, Carrier EJ, R\u00e1bano A, Hillard CJ et al (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains. J Neurosci 23:11136\u201311141","journal-title":"J Neurosci"},{"key":"597_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1517\/13543784.2014.905542","volume":"23","author":"C Berk","year":"2014","unstructured":"Berk C, Paul G, Sabbagh M (2014) Investigational drugs in Alzheimer\u2019s disease: current progress. Expert Opin Investig Drugs 23:837\u2013846","journal-title":"Expert Opin Investig Drugs"},{"key":"597_CR18","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1242\/dev.125.16.3179","volume":"125","author":"F Berrendero","year":"1998","unstructured":"Berrendero F, Garc\u00eda-Gil L, Hern\u00e1ndez ML, Romero J, Cebeira M, de Miguel R et al (1998a) Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 125:3179\u20133188","journal-title":"Development"},{"key":"597_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0925-4439(98)00042-8","volume":"1407","author":"F Berrendero","year":"1998","unstructured":"Berrendero F, Romero J, Garc\u00eda-Gil L, Su\u00e1rez I, De la Cruz P, Ramos JA et al (1998b) Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim Biophys Acta 1407:205\u2013214","journal-title":"Biochim Biophys Acta"},{"key":"597_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R","volume":"33","author":"F Berrendero","year":"1999","unstructured":"Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fern\u00e1ndez-Ruiz J (1999) Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33:181\u2013191","journal-title":"Synapse"},{"key":"597_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111961","volume":"221","author":"UR Bhandari","year":"2024","unstructured":"Bhandari UR, Danish SM, Ahmad S, Ikram M, Nadaf A, Hasan N et al (2024) New opportunities for antioxidants in amelioration of neurodegenerative diseases. Mech Ageing Dev 221:111961","journal-title":"Mech Ageing Dev"},{"key":"597_CR22","doi-asserted-by":"publisher","first-page":"15670","DOI":"10.1073\/pnas.0504640102","volume":"102","author":"A Bilkei-Gorzo","year":"2005","unstructured":"Bilkei-Gorzo A, Racz I, Valverde O, Otto M, Michel K, Sastre M et al (2005) Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci USA 102:15670\u201315675","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR23","first-page":"3326","volume":"367","author":"A Bilkei-Gorzo","year":"2012","unstructured":"Bilkei-Gorzo A (2012) The endocannabinoid system in normal and pathological brain ageing. Philos Trans R Soc Lond Ser B Biol Sci 367:3326\u20133341","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"597_CR24","doi-asserted-by":"publisher","first-page":"200.e11","DOI":"10.1016\/j.neurobiolaging.2010.07.009","volume":"33","author":"A Bilkei-Gorzo","year":"2012","unstructured":"Bilkei-Gorzo A, Drews E, Albayram \u00d6, Piyanova A, Gaffal E, Tueting T et al (2012) Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1\u2212\/\u2212 mice. Neurobiol Aging 33:200.e11\u2013200.e22","journal-title":"Neurobiol Aging"},{"key":"597_CR25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nm.4311","volume":"23","author":"A Bilkei-Gorzo","year":"2017","unstructured":"Bilkei-Gorzo A, Albayram O, Draffehn A, Michel K, Piyanova A, Oppenheimer H et al (2017) A. A chronic low dose of \u03949-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat Med 23:782\u2013787","journal-title":"Nat Med"},{"key":"597_CR26","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.2174\/138161208785740081","volume":"14","author":"LG Bilsland","year":"2008","unstructured":"Bilsland LG, Greensmith L (2008) The endocannabinoid system in amyotrophic lateral sclerosis. Curr Pharm Des 14:2306\u20132316","journal-title":"Curr Pharm Des"},{"key":"597_CR27","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1523\/JNEUROSCI.23-09-03807.2003","volume":"23","author":"EM Blalock","year":"2003","unstructured":"Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC et al (2003) Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23:3807\u20133819","journal-title":"J Neurosci"},{"key":"597_CR28","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.3390\/ijms25084204","volume":"25","author":"NM Blebea","year":"2024","unstructured":"Blebea NM, Pricopie AI, Vlad RA, Hancu G (2024) Phytocannabinoids: exploring pharmacological profiles and their impact on therapeutical use. Int J Mol Sci 25:4204","journal-title":"Int J Mol Sci"},{"key":"597_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/biom14040402","volume":"14","author":"SC Bondy","year":"2024","unstructured":"Bondy SC (2024) Mitochondrial dysfunction as the major basis of brain aging. Biomolecules 14:402","journal-title":"Biomolecules"},{"key":"597_CR30","doi-asserted-by":"publisher","first-page":"1401706","DOI":"10.3389\/fnins.2024.1401706","volume":"18","author":"D Bradford","year":"2024","unstructured":"Bradford D, Rodgers KE (2024) Advancements and challenges in amyotrophic lateral sclerosis. Front Neurosci 18:1401706","journal-title":"Front Neurosci"},{"key":"597_CR31","doi-asserted-by":"publisher","first-page":"29166","DOI":"10.1074\/jbc.M110.217463","volume":"286","author":"GC Brailoiu","year":"2011","unstructured":"Brailoiu GC, Oprea TI, Zhao P, Abood ME, Brailoiu E (2011) Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide. J Biol Chem 286:29166\u201329174","journal-title":"J Biol Chem"},{"key":"597_CR32","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.3390\/molecules26247643","volume":"26","author":"S Burgaz","year":"2021","unstructured":"Burgaz S, Garc\u00eda C, Gonzalo-Consuegra C, G\u00f3mez-Almer\u00eda M, Ruiz-Pino F, Unciti JD et al (2021) Preclinical investigation in neuroprotective effects of the GPR55 ligand VCE-006.1 in experimental models of Parkinson\u2019s disease and amyotrophic lateral sclerosis. Molecules 26:7643","journal-title":"Molecules"},{"key":"597_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1471-4159.2005.03074.x","volume":"93","author":"E Butovsky","year":"2005","unstructured":"Butovsky E, Juknat A, Goncharov I, Elbaz J, Eilam R, Zangen A et al (2005) In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Delta-tetrahydrocannabinol. J Neurochem 93:802\u2013811","journal-title":"J Neurochem"},{"key":"597_CR34","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409000957","volume":"11","author":"GA Cabral","year":"2009","unstructured":"Cabral GA, Griffin-Thomas L (2009) Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med 11:e3","journal-title":"Expert Rev Mol Med"},{"key":"597_CR35","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.3390\/ijms25073733","volume":"25","author":"A Carles","year":"2024","unstructured":"Carles A, Freyssin A, Perin-Dureau F, Rubinstenn G, Maurice T (2024) Targeting N-methyl-d-aspartate receptors in neurodegenerative diseases. Int J Mol Sci 25:3733","journal-title":"Int J Mol Sci"},{"key":"597_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(09)00401-2","volume":"84","author":"MT Caserta","year":"2009","unstructured":"Caserta MT, Bannon Y, Fernandez F, Giunta B, Schoenberg MR, Tan J (2009) Normal brain aging clinical, immunological, neuropsychological, and neuroimaging features. Int Rev Neurobiol 84:1\u201319","journal-title":"Int Rev Neurobiol"},{"key":"597_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnins.2017.00030","volume":"11","author":"T Cassano","year":"2017","unstructured":"Cassano T, Calcagnini S, Pace L, De Marco F, Romano A, Gaetani S (2017) Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target. Front Neurosci 11:30","journal-title":"Front Neurosci"},{"key":"597_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuropharm.2017.08.017","volume":"125","author":"M Celorrio","year":"2017","unstructured":"Celorrio M, Rojo-Bustamante E, Fern\u00e1ndez-Su\u00e1rez D, S\u00e1ez E, Estella-Hermoso de Mendoza A, M\u00fcller CE et al (2017) GPR55: a therapeutic target for Parkinson\u2019s disease? Neuropharmacology 125:319\u2013332","journal-title":"Neuropharmacology"},{"key":"597_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108394","volume":"244","author":"C Chen","year":"2023","unstructured":"Chen C (2023) Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases. Pharmacol Ther 244:108394","journal-title":"Pharmacol Ther"},{"key":"597_CR40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","volume":"182","author":"IY Choi","year":"2013","unstructured":"Choi IY, Ju C, Anthony Jalin AM, Lee DI, Prather PL, Kim WK (2013) Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury. Am J Pathol 182:928\u2013939","journal-title":"Am J Pathol"},{"key":"597_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-0716-2728-0_16","volume":"2576","author":"F Ciaramellano","year":"2023","unstructured":"Ciaramellano F, Fanti F, Scipioni L, Maccarrone M, Oddi S (2023) Endocannabinoid metabolism and transport as drug targets. Methods Mol Biol 2576:201\u2013211","journal-title":"Methods Mol Biol"},{"key":"597_CR42","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cvsm.2010.05.001","volume":"40","author":"JR Coates","year":"2010","unstructured":"Coates JR, Wininger FA (2010) Canine degenerative myelopathy. Vet Clin North Am Small Anim Pract 40:929\u2013950","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"597_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108678","volume":"195","author":"A Covelo","year":"2021","unstructured":"Covelo A, Eraso-Pichot A, Fern\u00e1ndez-Moncada I, Serrat R, Marsicano G (2021) CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactions. Neuropharmacology 195:108678","journal-title":"Neuropharmacology"},{"key":"597_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 16:9\u201329","journal-title":"Nat Rev Neurol"},{"key":"597_CR45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jcmgh.2022.05.015","volume":"14","author":"H Cuddihey","year":"2022","unstructured":"Cuddihey H, MacNaughton WK, Sharkey KA (2022) Role of the endocannabinoid system in the regulation of intestinal homeostasis. Cell Mol Gastroenterol Hepatol 14:947\u2013963","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"597_CR46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40263-024-01103-1","volume":"38","author":"JL Cummings","year":"2024","unstructured":"Cummings JL, Osse AML, Kinney JW, Cammann D, Chen J (2024) Alzheimer\u2019s disease: combination therapies and clinical trials for combination therapy development. CNS Drugs 38:613\u2013624","journal-title":"CNS Drugs"},{"key":"597_CR47","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/febs.12125","volume":"280","author":"C D\u2019Addario","year":"2013","unstructured":"D\u2019Addario C, Di Francesco A, Pucci M, Finazzi Agr\u00f2 A, Maccarrone M (2013) Epigenetic mechanisms and endocannabinoid signalling. FEBS J 280:1905\u20131917","journal-title":"FEBS J"},{"key":"597_CR48","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.3390\/molecules27217207","volume":"27","author":"HG Dailah","year":"2022","unstructured":"Dailah HG (2022) Potential of therapeutic small molecules in apoptosis regulation in the treatment of neurodegenerative diseases: an updated review. Molecules 27:7207","journal-title":"Molecules"},{"key":"597_CR49","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","volume":"22","author":"M Delenclos","year":"2016","unstructured":"Delenclos M, Jones DR, McLean PJ, Uitti RJ (2016) Biomarkers in Parkinson\u2019s disease: advances and strategies. Parkinsonism Relat Disord 22:S106\u2013S110","journal-title":"Parkinsonism Relat Disord"},{"key":"597_CR50","first-page":"87","volume":"35","author":"HU Demuth","year":"2017","unstructured":"Demuth HU, Dijkhuizen RM, Farr TD, Gelderblom M, Horsburgh K, Iadecola C et al (2017) Recent progress in translational research on neurovascular and neurodegenerative disorders. Restor Neurol Neurosci 35:87\u2013103","journal-title":"Restor Neurol Neurosci"},{"key":"597_CR51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s42003-023-05034-3","volume":"6","author":"AA De Sousa","year":"2023","unstructured":"De Sousa AA, Rigby Dames BA, Graff EC, Mohamedelhassan R, Vassilopoulos T, Charvet CJ (2023) Going beyond established model systems of Alzheimer\u2019s disease: companion animals provide novel insights into the neurobiology of aging. Commun Biol 6:655","journal-title":"Commun Biol"},{"key":"597_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn3876","volume":"16","author":"V Di Marzo","year":"2015","unstructured":"Di Marzo V, Stella N, Zimmer A (2015) Endocannabinoid signalling and the deteriorating brain. Nat Rev Neurosci 16:30\u201342","journal-title":"Nat Rev Neurosci"},{"key":"597_CR53","first-page":"3229","volume":"367","author":"J D\u00edaz-Alonso","year":"2012","unstructured":"D\u00edaz-Alonso J, Guzm\u00e1n M, Galve-Roperh I (2012) Endocannabinoids via CB\u2081 receptors act as neurogenic niche cues during cortical development. Philos Trans R Soc Lond Ser B Biol Sci 367:3229\u20133241","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"597_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0749-0739(17)30258-4","volume":"13","author":"TJ Divers","year":"1997","unstructured":"Divers TJ, Mohammed HO, Cummings JF (1997) Equine motor neuron disease. Vet Clin North Am Equine Pract 13:97\u2013105","journal-title":"Vet Clin North Am Equine Pract"},{"key":"597_CR55","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K et al (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386","journal-title":"Neurology"},{"key":"597_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.crneur.2021.100012","volume":"2","author":"RL Doser","year":"2021","unstructured":"Doser RL, Hoerndli FJ (2021) Regulation of neuronal excitability by reactive oxygen species and calcium signaling: insights into brain aging. Curr Res Neurobiol 2:100012","journal-title":"Curr Res Neurobiol"},{"key":"597_CR57","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pneurobio.2010.06.001","volume":"92","author":"KL Double","year":"2010","unstructured":"Double KL, Reyes S, Werry EL, Halliday GM (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol 92:316\u2013329","journal-title":"Prog Neurobiol"},{"key":"597_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2011.10.019","volume":"60","author":"JM Duarte","year":"2012","unstructured":"Duarte JM, Ferreira SG, Carvalho RA, Cunha RA, K\u00f6falvi A (2012) CB\u2081 receptor activation inhibits neuronal and astrocytic intermediary metabolism in the rat hippocampus. Neurochem Int 60:1\u20138","journal-title":"Neurochem Int"},{"key":"597_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108555","volume":"190","author":"SS Duffy","year":"2021","unstructured":"Duffy SS, Hayes JP, Fiore NT, Moalem-Taylor G (2021) The cannabinoid system and microglia in health and disease. Neuropharmacology 190:108555","journal-title":"Neuropharmacology"},{"key":"597_CR60","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00335-017-9687-6","volume":"28","author":"SL Eaton","year":"2017","unstructured":"Eaton SL, Wishart TM (2017) Bridging the gap: large animal models in neurodegenerative research. Mamm Genome 28:324\u2013337","journal-title":"Mamm Genome"},{"key":"597_CR61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/cancers13030419","volume":"13","author":"A Ellert-Miklaszewska","year":"2021","unstructured":"Ellert-Miklaszewska A, Ciechomska IA, Kaminska B (2021) Synthetic cannabinoids induce autophagy and mitochondrial apoptotic pathways in human glioblastoma cells independently of deficiency in TP53 or PTEN tumor suppressors. Cancers (Basel) 13:419","journal-title":"Cancers (Basel)"},{"key":"597_CR62","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00001756-199312000-00013","volume":"5","author":"N Eshhar","year":"1993","unstructured":"Eshhar N, Striem S, Biegon A (1993) HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture. Neuroreport 5:237\u2013240","journal-title":"Neuroreport"},{"key":"597_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11481-015-9602-4","volume":"10","author":"F Espejo-Porras","year":"2015","unstructured":"Espejo-Porras F, Piscitelli F, Verde R, Ramos JA, Di Marzo V, de Lago E et al (2015) Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders. J Neuroimmune Pharmacol 10:233\u2013244","journal-title":"J Neuroimmune Pharmacol"},{"key":"597_CR64","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/bph.14216","volume":"176","author":"F Espejo-Porras","year":"2019","unstructured":"Espejo-Porras F, Garc\u00eda-Toscano L, Rodr\u00edguez-Cueto C, Santos-Garc\u00eda I, de Lago E, Fernandez-Ruiz J (2019) Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis. Br J Pharmacol 176:1585\u20131600","journal-title":"Br J Pharmacol"},{"key":"597_CR65","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s40120-023-00541-1","volume":"12","author":"A Esquer","year":"2023","unstructured":"Esquer A, Blanc F, Collongues N (2023) Immunotherapies targeting amyloid and tau protein in Alzheimer\u2019s disease: should we move away from diseases and focus on biological targets? A systematic review and expert opinion. Neurol Ther 12:1883\u20131907","journal-title":"Neurol Ther"},{"key":"597_CR66","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/bph.12492","volume":"171","author":"SG Fagan","year":"2014","unstructured":"Fagan SG, Campbell VA (2014) The influence of cannabinoids on generic traits of neurodegeneration. Br J Pharmacol 171:1347\u20131360","journal-title":"Br J Pharmacol"},{"key":"597_CR67","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s11064-016-2053-3","volume":"41","author":"P Farzanehfar","year":"2016","unstructured":"Farzanehfar P (2016) Towards a better treatment option for Parkinson\u2019s disease: a review of adult neurogenesis. Neurochem Res 41:3161\u20133170","journal-title":"Neurochem Res"},{"key":"597_CR68","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1073\/pnas.86.23.9584","volume":"86","author":"JJ Feigenbaum","year":"1989","unstructured":"Feigenbaum JJ, Bergmann F, Richmond SA, Mechoulam R, Nadler V, Kloog Y et al (1989) Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci USA 86:9584\u20139587","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR69","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/jnc.15922","volume":"168","author":"I Fern\u00e1ndez-Moncada","year":"2024","unstructured":"Fern\u00e1ndez-Moncada I, Rodrigues RS, Fundazuri UB, Bellocchio L, Marsicano G (2024) Type-1 cannabinoid receptors and their ever-expanding roles in brain energy processes. J Neurochem 168:693\u2013703","journal-title":"J Neurochem"},{"key":"597_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0166-2236(99)01491-5","volume":"23","author":"J Fern\u00e1ndez-Ruiz","year":"2000","unstructured":"Fern\u00e1ndez-Ruiz J, Berrendero F, Hern\u00e1ndez ML, Ramos JA (2000) The endogenous cannabinoid system and brain development. Trends Neurosci 23:14\u201320","journal-title":"Trends Neurosci"},{"key":"597_CR71","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1476-5381.2008.00088.x","volume":"156","author":"J Fern\u00e1ndez-Ruiz","year":"2009","unstructured":"Fern\u00e1ndez-Ruiz J (2009) The endocannabinoid system as a target for the treatment of motor dysfunction. Br J Pharmacol 156:1029\u20131040","journal-title":"Br J Pharmacol"},{"key":"597_CR72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","volume":"231","author":"J Fern\u00e1ndez-Ruiz","year":"2015","unstructured":"Fern\u00e1ndez-Ruiz J, Romero J, Ramos JA (2015a) Endocannabinoids and neurodegenerative disorders: Parkinson\u2019s disease, Huntington\u2019s chorea, Alzheimer\u2019s disease, and others. Handb Exp Pharmacol 231:233\u2013259","journal-title":"Handb Exp Pharmacol"},{"key":"597_CR73","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","volume":"12","author":"J Fern\u00e1ndez-Ruiz","year":"2015","unstructured":"Fern\u00e1ndez-Ruiz J, Moro MA, Mart\u00ednez-Orgado J (2015b) Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: from preclinical models to clinical applications. Neurotherapeutics 12:793\u2013806","journal-title":"Neurotherapeutics"},{"key":"597_CR74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.mie.2017.06.021","volume":"593","author":"J Fern\u00e1ndez-Ruiz","year":"2017","unstructured":"Fern\u00e1ndez-Ruiz J, G\u00f3mez-Ruiz M, Garc\u00eda C, Hern\u00e1ndez M, Ramos JA (2017) Modeling neurodegenerative disorders for developing cannabinoid-based neuroprotective therapies. Methods Enzymol 593:175\u2013198","journal-title":"Methods Enzymol"},{"key":"597_CR75","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/bph.14382","volume":"176","author":"J Fern\u00e1ndez-Ruiz","year":"2019","unstructured":"Fern\u00e1ndez-Ruiz J (2019) The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes. Br J Pharmacol 176:1370\u20131383","journal-title":"Br J Pharmacol"},{"key":"597_CR76","first-page":"10","volume-title":"New tools to interrogate endocannabinoid signalling: from natural compounds to synthetic drugs","author":"J Fern\u00e1ndez-Ruiz","year":"2021","unstructured":"Fern\u00e1ndez-Ruiz J, Sagredo O, de Lago E (2021) Chapter 2 \u2013 Phytocannabinoids versus endocannabinoids. A modern view of the endocannabinoid system. In: Maccarrone M (ed) New tools to interrogate endocannabinoid signalling: from natural compounds to synthetic drugs. Royal Society of Chemistry, pp 10\u201347"},{"key":"597_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114384","volume":"364","author":"A Figueiredo","year":"2023","unstructured":"Figueiredo A, Cheer JF (2023) Endocannabinoid regulation of hippocampus-dependent memory. Exp Neurol 364:114384","journal-title":"Exp Neurol"},{"key":"597_CR78","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/WNF.0000000000000132","volume":"39","author":"K Fija\u0142","year":"2016","unstructured":"Fija\u0142 K, Filip M (2016) Clinical\/therapeutic approaches for cannabinoid ligands in central and peripheral nervous system diseases: mini review. Clin Neuropharmacol 39:94\u2013101","journal-title":"Clin Neuropharmacol"},{"key":"597_CR79","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","volume":"78","author":"AI Fraguas-S\u00e1nchez","year":"2018","unstructured":"Fraguas-S\u00e1nchez AI, Torres-Su\u00e1rez AI (2018) Medical use of cannabinoids. Drugs 78:1665\u20131703","journal-title":"Drugs"},{"key":"597_CR80","first-page":"15","volume":"22","author":"AM Franceschi","year":"2022","unstructured":"Franceschi AM, Petrover DR, Giliberto L, Clouston SAP, Gordon ML (2022) Semiquantitative approach to amyloid positron emission tomography interpretation in clinical practice. World J Nucl Med 22:15\u201321","journal-title":"World J Nucl Med"},{"key":"597_CR81","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","volume":"16","author":"GB Frisoni","year":"2017","unstructured":"Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K et al (2017) Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers. Lancet Neurol 16:661\u2013676","journal-title":"Lancet Neurol"},{"key":"597_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jns.2014.04.034","volume":"342","author":"M Fujii","year":"2014","unstructured":"Fujii M, Sherchan P, Krafft PR, Rolland WB, Soejima Y, Zhang JH (2014) Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats. J Neurol Sci 342:101\u2013106","journal-title":"J Neurol Sci"},{"key":"597_CR83","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.plipres.2013.05.004","volume":"52","author":"I Galve-Roperh","year":"2013","unstructured":"Galve-Roperh I, Chiurchi\u00f9 V, D\u00edaz-Alonso J, Bari M, Guzm\u00e1n M, Maccarrone M (2013) Cannabinoid receptor signaling in progenitor\/stem cell proliferation and differentiation. Prog Lipid Res 52:633\u2013650","journal-title":"Prog Lipid Res"},{"key":"597_CR84","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","volume":"30","author":"Y Gao","year":"2010","unstructured":"Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M et al (2010) Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30:2017\u20132024","journal-title":"J Neurosci"},{"key":"597_CR85","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s12264-022-00959-x","volume":"38","author":"Z Gao","year":"2022","unstructured":"Gao Z, Pang Z, Chen Y, Lei G, Zhu S, Li G et al (2022) Restoring after central nervous system injuries: neural mechanisms and translational applications of motor recovery. Neurosci Bull 38:1569\u20131587","journal-title":"Neurosci Bull"},{"key":"597_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-021-01196-5","volume":"9","author":"M Gal\u00e1n-Ganga","year":"2021","unstructured":"Gal\u00e1n-Ganga M, Rodr\u00edguez-Cueto C, Merch\u00e1n-Rubira J, Hern\u00e1ndez F, \u00c1vila J, Posada-Ayala M et al (2021) Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration. Acta Neuropathol Commun 9:90","journal-title":"Acta Neuropathol Commun"},{"key":"597_CR87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.arr.2018.02.003","volume":"43","author":"O Garaschuk","year":"2018","unstructured":"Garaschuk O, Semchyshyn HM, Lushchak VI (2018) Healthy brain aging: interplay between reactive species, inflammation and energy supply. Ageing Res Rev 43:26\u201345","journal-title":"Ageing Res Rev"},{"key":"597_CR88","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1474-9726.2008.00410.x","volume":"7","author":"S Garc\u00eda-Matas","year":"2008","unstructured":"Garc\u00eda-Matas S, Gutierrez-Cuesta J, Coto-Montes A, Rubio-Acero R, D\u00edez-Vives C, Camins A et al (2008) Dysfunction of astrocytes in senescence-accelerated mice SAMP8 reduces their neuroprotective capacity. Aging Cell 7:630\u2013640","journal-title":"Aging Cell"},{"key":"597_CR89","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.2174\/09298673113209990112","volume":"20","author":"WJ Geldenhuys","year":"2013","unstructured":"Geldenhuys WJ, Van der Schyf CJ (2013) Rationally designed multi-targeted agents against neurodegenerative diseases. Curr Med Chem 20:1662\u20131672","journal-title":"Curr Med Chem"},{"key":"597_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105237","volume":"162","author":"TM Gomes","year":"2020","unstructured":"Gomes TM, Dias da Silva D, Carmo H, Carvalho F, Silva JP (2020) Epigenetics and the endocannabinoid system signaling: an intricate interplay modulating neurodevelopment. Pharmacol Res 162:105237","journal-title":"Pharmacol Res"},{"key":"597_CR91","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-0716-2728-0_6","volume":"2576","author":"M G\u00f3mez-Ca\u00f1as","year":"2023","unstructured":"G\u00f3mez-Ca\u00f1as M, Rodr\u00edguez-Cueto C, Satta V, Hern\u00e1ndez-Fisac I, Navarro E, Fern\u00e1ndez-Ruiz J (2023) Endocannabinoid-binding receptors as drug targets. Methods Mol Biol 2576:67\u201394","journal-title":"Methods Mol Biol"},{"key":"597_CR92","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","volume":"64","author":"Y G\u00f3mez-G\u00e1lvez","year":"2016","unstructured":"G\u00f3mez-G\u00e1lvez Y, Palomo-Garo C, Fern\u00e1ndez-Ruiz J, Garc\u00eda C (2016) Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson\u2019s disease. Prog Neuro-Psychopharmacol Biol Psychiatry 64:200\u2013208","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"597_CR93","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.mcn.2008.05.001","volume":"38","author":"MB Goncalves","year":"2008","unstructured":"Goncalves MB, Suetterlin P, Yip P, Molina-Holgado F, Walker DJ, Oudin MJ et al (2008) A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol Cell Neurosci 38:526\u2013536","journal-title":"Mol Cell Neurosci"},{"key":"597_CR94","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2174\/1385272823666191021124443","volume":"18","author":"VS Gontijo","year":"2020","unstructured":"Gontijo VS, Viegas FPD, Ortiz CJC, de Freitas SM, Damasio CM, Rosa MC et al (2020) Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases. Curr Neuropharmacol 18:348\u2013407","journal-title":"Curr Neuropharmacol"},{"key":"597_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116473","volume":"174","author":"C Gonzalo-Consuegra","year":"2024","unstructured":"Gonzalo-Consuegra C, Santos-Garc\u00eda I, Garc\u00eda-Toscano L, Mart\u00edn-Baquero R, Rodr\u00edguez-Cueto C, Wittwer MB et al (2024) Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice. Biomed Pharmacother 174:116473","journal-title":"Biomed Pharmacother"},{"key":"597_CR96","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrneurol.2011.147","volume":"7","author":"PH Gordon","year":"2011","unstructured":"Gordon PH, Meininger V (2011) How can we improve clinical trials in amyotrophic lateral sclerosis? Nat Rev Neurol 7:650\u2013654","journal-title":"Nat Rev Neurol"},{"key":"597_CR97","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0009-3084(02)00161-5","volume":"121","author":"E Grigorenko","year":"2002","unstructured":"Grigorenko E, Kittler J, Clayton C, Wallace D, Zhuang S, Bridges D et al (2002) Assessment of cannabinoid induced gene changes: tolerance and neuroprotection. Chem Phys Lipids 121:257\u2013266","journal-title":"Chem Phys Lipids"},{"key":"597_CR98","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jnc.14037","volume":"143","author":"A Grimm","year":"2017","unstructured":"Grimm A, Eckert A (2017) Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 143:418\u2013431","journal-title":"J Neurochem"},{"key":"597_CR99","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/can.2021.0101","volume":"7","author":"K Hagan","year":"2022","unstructured":"Hagan K, Varelas P, Zheng H (2022) Endocannabinoid system of the blood-brain barrier: current understandings and therapeutic potentials. Cannabis Cannabinoid Res 7:561\u2013568","journal-title":"Cannabis Cannabinoid Res"},{"key":"597_CR100","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neuropharm.2011.02.016","volume":"61","author":"S Haj-Dahmane","year":"2011","unstructured":"Haj-Dahmane S, Shen RY (2011) Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology 61:414\u2013420","journal-title":"Neuropharmacology"},{"key":"597_CR101","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230173","volume":"308","author":"S Haller","year":"2023","unstructured":"Haller S, J\u00e4ger HR, Vernooij MW, Barkhof F (2023) Neuroimaging in dementia: more than typical Alzheimer\u2019s disease. Radiology 308:e230173","journal-title":"Radiology"},{"key":"597_CR102","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/ejn.12207","volume":"37","author":"LK Hamilton","year":"2013","unstructured":"Hamilton LK, Jopp\u00e9 SE, Cochard LM, Fernandes KJ (2013) Aging and neurogenesis in the adult forebrain: what we have learned and where we should go from here. Eur J Neurosci 37:1978\u20131986","journal-title":"Eur J Neurosci"},{"key":"597_CR103","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","volume":"95","author":"AJ Hampson","year":"1998","unstructured":"Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (\u2212)\u03949-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95:8268\u20138273","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tips.2006.12.004","volume":"28","author":"T Harkany","year":"2007","unstructured":"Harkany T, Guzm\u00e1n M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K (2007) The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28:83\u201392","journal-title":"Trends Pharmacol Sci"},{"key":"597_CR105","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/bs.apha.2021.10.006","volume":"93","author":"B Hempel","year":"2022","unstructured":"Hempel B, Xi ZX (2022) Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond. Adv Pharmacol 93:275\u2013333","journal-title":"Adv Pharmacol"},{"key":"597_CR106","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00702-023-02719-1","volume":"131","author":"U Hidding","year":"2024","unstructured":"Hidding U, Mainka T, Buhmann C (2024) Therapeutic use of medical Cannabis in neurological diseases: a clinical update. J Neural Transm (Vienna) 131:117\u2013126","journal-title":"J Neural Transm (Vienna)"},{"key":"597_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2017.tb00740.x","volume":"7","author":"CJ Hillard","year":"2016","unstructured":"Hillard CJ, Beatka M, Sarvaideo J (2016) Endocannabinoid signaling and the hypothalamic-pituitary-adrenal axis. Compr Physiol 7:1\u201315","journal-title":"Compr Physiol"},{"key":"597_CR108","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/path.4654","volume":"238","author":"IE Holm","year":"2016","unstructured":"Holm IE, Alstrup AK, Luo Y (2016) Genetically modified pig models for neurodegenerative disorders. J Pathol 238:267\u2013287","journal-title":"J Pathol"},{"key":"597_CR109","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pharmthera.2016.02.009","volume":"160","author":"A Hoque","year":"2016","unstructured":"Hoque A, Hossain MI, Ameen SS, Ang CS, Williamson N, Ng DC et al (2016) A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Pharmacol Ther 160:159\u2013179","journal-title":"Pharmacol Ther"},{"key":"597_CR110","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/cpt.3341","volume":"116","author":"C Huang","year":"2024","unstructured":"Huang C, Zheng X, Yan S, Zhang Z (2024) Advances in clinical therapies for Huntington\u2019s disease and the promise of multi-targeted\/functional drugs based on Clinicaltrials.gov. Clin Pharmacol Ther 116:1452","journal-title":"Clin Pharmacol Ther"},{"key":"597_CR111","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/glia.23911","volume":"69","author":"A Huerga-G\u00f3mez","year":"2021","unstructured":"Huerga-G\u00f3mez A, Aguado T, S\u00e1nchez-de la Torre A, Bernal-Chico A, Matute C, Mato S et al (2021) \u03949-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo. Glia 69:532\u2013545","journal-title":"Glia"},{"key":"597_CR112","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.lfs.2009.06.003","volume":"86","author":"J Hwang","year":"2010","unstructured":"Hwang J, Adamson C, Butler D, Janero DR, Makriyannis A, Bahr BA (2010) Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality. Life Sci 86:615\u2013623","journal-title":"Life Sci"},{"key":"597_CR113","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fnins.2018.00733","volume":"12","author":"AA Ilyasov","year":"2018","unstructured":"Ilyasov AA, Milligan CE, Pharr EP, Howlett AC (2018) The endocannabinoid system and oligodendrocytes in health and disease. Front Neurosci 12:733","journal-title":"Front Neurosci"},{"key":"597_CR114","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","volume":"107","author":"A Ionescu-Tucker","year":"2021","unstructured":"Ionescu-Tucker A, Cotman CW (2021) Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease. Neurobiol Aging 107:86\u201395","journal-title":"Neurobiol Aging"},{"key":"597_CR115","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1515\/revneuro-2018-0084","volume":"30","author":"NK Isaev","year":"2019","unstructured":"Isaev NK, Stelmashook EV, Genrikhs EE (2019) Neurogenesis and brain aging. Rev Neurosci 30:573\u2013580","journal-title":"Rev Neurosci"},{"key":"597_CR116","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1474-4422(23)00128-X","volume":"22","author":"WJ Jagust","year":"2023","unstructured":"Jagust WJ, Teunissen CE, DeCarli C (2023) The complex pathway between amyloid \u03b2 and cognition: implications for therapy. Lancet Neurol 22:847\u2013857","journal-title":"Lancet Neurol"},{"key":"597_CR117","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1073\/pnas.98.4.1930","volume":"98","author":"CH Jiang","year":"2001","unstructured":"Jiang CH, Tsien JZ, Schultz PG, Hu Y (2001) The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc Natl Acad Sci USA 98:1930\u20131934","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR118","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1172\/JCI25509","volume":"115","author":"W Jiang","year":"2005","unstructured":"Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G et al (2005) Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115:3104\u20133116","journal-title":"J Clin Invest"},{"key":"597_CR119","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1124\/mol.66.2.204","volume":"66","author":"K Jin","year":"2004","unstructured":"Jin K, Xie L, Kim SH, Parmentier-Batteur S, Sun Y, Mao XO et al (2004) Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol 66:204\u2013208","journal-title":"Mol Pharmacol"},{"key":"597_CR120","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1111\/bph.15469","volume":"179","author":"M Kaczocha","year":"2022","unstructured":"Kaczocha M, Haj-Dahmane S (2022) Mechanisms of endocannabinoid transport in the brain. Br J Pharmacol 179:4300\u20134310","journal-title":"Br J Pharmacol"},{"key":"597_CR121","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/glia.22560","volume":"61","author":"S Kallendrusch","year":"2013","unstructured":"Kallendrusch S, Kremzow S, Nowicki M, Grabiec U, Winkelmann R, Benz A et al (2013) The G protein-coupled receptor 55 ligand l-\u03b1-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion. Glia 61:1822\u20131831","journal-title":"Glia"},{"key":"597_CR122","first-page":"1","volume":"91","author":"NE Kaminski","year":"2021","unstructured":"Kaminski NE, Kaplan BLF (2021) Immunomodulation by cannabinoids: current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application. Adv Pharmacol 91:1\u201359","journal-title":"Adv Pharmacol"},{"key":"597_CR123","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/19390211.2020.1790708","volume":"17","author":"E Karimian Azari","year":"2020","unstructured":"Karimian Azari E, Kerrigan A, O\u2019Connor A (2020) Naturally occurring cannabinoids and their role in modulation of cardiovascular health. J Diet Suppl 17:625\u2013650","journal-title":"J Diet Suppl"},{"key":"597_CR124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.12703\/r\/10-77","volume":"10","author":"J Kaye","year":"2021","unstructured":"Kaye J, Reisine T, Finkbeiner S (2021) Huntington\u2019s disease mouse models: unraveling the pathology caused by CAG repeat expansion. Fac Rev 10:77","journal-title":"Fac Rev"},{"key":"597_CR125","first-page":"870","volume":"58","author":"M Kessiova","year":"2006","unstructured":"Kessiova M, Alexandrova A, Georgieva A, Kirkova M, Todorov S (2006) In vitro effects of CB1 receptor ligands on lipid peroxidation and antioxidant defense systems in the rat brain. Pharmacol Rep 58:870\u2013875","journal-title":"Pharmacol Rep"},{"key":"597_CR126","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/1871527315666160202124518","volume":"15","author":"TA Khan","year":"2016","unstructured":"Khan TA, Hassan I, Ahmad A, Perveen A, Aman S, Quddusi S et al (2016) Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders. CNS Neurol Disord Drug Targets 15:310\u2013320","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"597_CR127","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.pmr.2022.04.011","volume":"33","author":"D Kharrazian","year":"2022","unstructured":"Kharrazian D (2022) Functional medicine approaches to neurodegeneration. Phys Med Rehabil Clin N Am 33:733\u2013743","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"597_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101465","volume":"72","author":"V Kluever","year":"2021","unstructured":"Kluever V, Fornasiero EF (2021) Principles of brain aging: status and challenges of modeling human molecular changes in mice. Ageing Res Rev 72:101465","journal-title":"Ageing Res Rev"},{"key":"597_CR129","doi-asserted-by":"publisher","first-page":"S323","DOI":"10.3233\/JPD-230429","volume":"14","author":"A Kluge","year":"2024","unstructured":"Kluge A, Iranzo A (2024) Biofluid detection of pathological \u03b1-synuclein in the prodromal phase of synucleinopathies. J Parkinsons Dis 14:S323","journal-title":"J Parkinsons Dis"},{"key":"597_CR130","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fnins.2017.00293","volume":"11","author":"M Koch","year":"2017","unstructured":"Koch M (2017) Cannabinoid receptor signaling in central regulation of feeding behavior: a mini-review. Front Neurosci 11:293","journal-title":"Front Neurosci"},{"key":"597_CR131","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.3390\/molecules26195984","volume":"26","author":"JA Komorowska-M\u00fcller","year":"2021","unstructured":"Komorowska-M\u00fcller JA, Rana T, Olabiyi BF, Zimmer A, Schm\u00f6le AC (2021) Cannabinoid receptor 2 alters social memory and microglial activity in an age-dependent manner. Molecules 26:5984","journal-title":"Molecules"},{"key":"597_CR132","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM (2017) Animal models of \u03b1-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci 18:515\u2013529","journal-title":"Nat Rev Neurosci"},{"key":"597_CR133","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A (2013) The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord 28:311\u2013318","journal-title":"Mov Disord"},{"key":"597_CR134","first-page":"473","volume":"66","author":"J Kudelova","year":"2015","unstructured":"Kudelova J, Fleischmannova J, Adamova E, Matalova E (2015) Pharmacological caspase inhibitors: research towards therapeutic perspectives. J Physiol Pharmacol 66:473\u2013482","journal-title":"J Physiol Pharmacol"},{"key":"597_CR135","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/978-3-030-12457-1_39","volume":"1131","author":"A Kumar","year":"2020","unstructured":"Kumar A (2020) Calcium signaling during brain aging and its influence on the hippocampal synaptic plasticity. Adv Exp Med Biol 1131:985\u20131012","journal-title":"Adv Exp Med Biol"},{"key":"597_CR136","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000521683","volume":"107","author":"CA Legare","year":"2022","unstructured":"Legare CA, Raup-Konsavage WM, Vrana KE (2022) Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacology 107:131\u2013149","journal-title":"Pharmacology"},{"key":"597_CR137","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0006-8993(03)02872-5","volume":"979","author":"P Liu","year":"2003","unstructured":"Liu P, Bilkey DK, Darlington CL, Smith PF (2003) Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes. Brain Res 979:235\u2013239","journal-title":"Brain Res"},{"key":"597_CR138","first-page":"CD009628","volume":"3","author":"G Lombardi","year":"2020","unstructured":"Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre AG et al (2020) Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer\u2019s disease in people with mild cognitive impairment. Cochrane Database Syst Rev 3:CD009628","journal-title":"Cochrane Database Syst Rev"},{"key":"597_CR139","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/biom11030433","volume":"11","author":"M Lorente-Pic\u00f3n","year":"2021","unstructured":"Lorente-Pic\u00f3n M, Laguna A (2021) New avenues for Parkinson\u2019s disease therapeutics: disease-modifying strategies based on the gut microbiota. Biomolecules 11:433","journal-title":"Biomolecules"},{"key":"597_CR140","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nature02661","volume":"429","author":"T Lu","year":"2004","unstructured":"Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429:883\u2013891","journal-title":"Nature"},{"key":"597_CR141","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1326-5-12","volume":"5","author":"XG Luo","year":"2010","unstructured":"Luo XG, Ding JQ, Chen SD (2010) Microglia in the aging brain: relevance to neurodegeneration. Mol Neurodegener 5:12","journal-title":"Mol Neurodegener"},{"key":"597_CR142","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1474-4422(05)70253-2","volume":"5","author":"AI Maas","year":"2006","unstructured":"Maas AI, Murray G, Henney H 3rd, Kassem N, Legrand V, Mangelus M et al (2006) Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol 5:38\u201345","journal-title":"Lancet Neurol"},{"key":"597_CR143","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1046\/j.1460-9568.2002.01957.x","volume":"15","author":"M Maccarrone","year":"2002","unstructured":"Maccarrone M, Valverde O, Barbaccia ML, Casta\u00f1\u00e9 A, Maldonado R, Ledent C et al (2002) Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci 15:1178\u20131186","journal-title":"Eur J Neurosci"},{"key":"597_CR144","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrn3846","volume":"15","author":"M Maccarrone","year":"2014","unstructured":"Maccarrone M, Guzm\u00e1n M, Mackie K, Doherty P, Harkany T (2014) Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci 15:786\u2013801","journal-title":"Nat Rev Neurosci"},{"key":"597_CR145","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/17512433.2017.1292849","volume":"10","author":"M Maccarrone","year":"2017","unstructured":"Maccarrone M, Maldonado R, Casas M, Henze T, Centonze D (2017) Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? Expert Rev Clin Pharmacol 10:443\u2013455","journal-title":"Expert Rev Clin Pharmacol"},{"key":"597_CR146","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","volume":"75","author":"M Maccarrone","year":"2023","unstructured":"Maccarrone M, Di Marzo V, Gertsch J, Grether U, Howlett AC, Hua T et al (2023) Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years. Pharmacol Rev 75:885\u2013958","journal-title":"Pharmacol Rev"},{"key":"597_CR147","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/jnr.24933","volume":"99","author":"SV Magham","year":"2021","unstructured":"Magham SV, Thaggikuppe Krishnamurthy P, Shaji N, Mani L, Balasubramanian S (2021) Cannabinoid receptor 2 selective agonists and Alzheimer\u2019s disease: an insight into the therapeutic potentials. J Neurosci Res 99:2888\u20132905","journal-title":"J Neurosci Res"},{"key":"597_CR148","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fimmu.2020.02021","volume":"11","author":"K Mallah","year":"2020","unstructured":"Mallah K, Couch C, Borucki DM, Toutonji A, Alshareef M, Tomlinson S (2020) Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here? Front Immunol 11:2021","journal-title":"Front Immunol"},{"key":"597_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.07.004","volume":"133","author":"R Mancuso","year":"2015","unstructured":"Mancuso R, Navarro X (2015) Amyotrophic lateral sclerosis: current perspectives from basic research to the clinic. Prog Neurobiol 133:1\u201326","journal-title":"Prog Neurobiol"},{"key":"597_CR150","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol 9:702\u2013716","journal-title":"Lancet Neurol"},{"key":"597_CR151","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","volume":"80","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80:448\u2013456","journal-title":"J Neurochem"},{"key":"597_CR152","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A et al (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84\u201388","journal-title":"Science"},{"key":"597_CR153","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1007\/s12035-019-1495-4","volume":"56","author":"E Mart\u00ednez-Pinilla","year":"2019","unstructured":"Mart\u00ednez-Pinilla E, Aguinaga D, Navarro G, Rico AJ, Oyarz\u00e1bal J, S\u00e1nchez-Arias JA et al (2019) Targeting CB1 and GPR55 endocannabinoid receptors as a potential neuroprotective approach for Parkinson\u2019s disease. Mol Neurobiol 56:5900\u20135910","journal-title":"Mol Neurobiol"},{"key":"597_CR154","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11064-006-9170-3","volume":"32","author":"MP Mattson","year":"2007","unstructured":"Mattson MP (2007) Mitochondrial regulation of neuronal plasticity. Neurochem Res 32:707\u2013715","journal-title":"Neurochem Res"},{"key":"597_CR155","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.2174\/1568026615666150610125715","volume":"15","author":"CH Mazucanti","year":"2015","unstructured":"Mazucanti CH, Cabral-Costa JV, Vasconcelos AR, Andreotti DZ, Scavone C, Kawamoto EM (2015) Longevity pathways (mTOR, SIRT, insulin\/IGF-1) as key modulatory targets on aging and neurodegeneration. Curr Top Med Chem 15:2116\u20132138","journal-title":"Curr Top Med Chem"},{"key":"597_CR156","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcdb.2017.08.024","volume":"70","author":"A Mazzatenta","year":"2017","unstructured":"Mazzatenta A, Carluccio A, Robbe D, Giulio CD, Cellerino A (2017) The companion dog as a unique translational model for aging. Semin Cell Dev Biol 70:141\u2013153","journal-title":"Semin Cell Dev Biol"},{"key":"597_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpmo.22","volume":"7","author":"MA McLellan","year":"2017","unstructured":"McLellan MA, Rosenthal NA, Pinto AR (2017) Cre-loxP-mediated recombination: general principles and experimental considerations. Curr Protoc Mouse Biol 7:1\u201312","journal-title":"Curr Protoc Mouse Biol"},{"key":"597_CR158","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11154-021-09682-w","volume":"23","author":"F Meah","year":"2022","unstructured":"Meah F, Lundholm M, Emanuele N, Amjed H, Poku C, Agrawal L, Emanuele MA (2022) The effects of cannabis and cannabinoids on the endocrine system. Rev Endocr Metab Disord 23:401\u2013420","journal-title":"Rev Endocr Metab Disord"},{"key":"597_CR159","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12035-007-8008-6","volume":"36","author":"R Mechoulam","year":"2007","unstructured":"Mechoulam R, Shohami E (2007) Endocannabinoids and traumatic brain injury. Mol Neurobiol 36:68\u201374","journal-title":"Mol Neurobiol"},{"key":"597_CR160","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.phrs.2017.04.024","volume":"121","author":"J Meldolesi","year":"2017","unstructured":"Meldolesi J (2017) Neurotrophin receptors in the pathogenesis, diagnosis and therapy of neurodegenerative diseases. Pharmacol Res 121:129\u2013137","journal-title":"Pharmacol Res"},{"key":"597_CR161","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/mds.26006","volume":"29","author":"L Menalled","year":"2014","unstructured":"Menalled L, Brunner D (2014) Animal models of Huntington\u2019s disease for translation to the clinic: best practices. Mov Disord 29:1375\u20131390","journal-title":"Mov Disord"},{"key":"597_CR162","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/npp.2017.143","volume":"43","author":"HC Meyer","year":"2018","unstructured":"Meyer HC, Lee FS, Gee DG (2018) The role of the endocannabinoid system and genetic variation in adolescent brain development. Neuropsychopharmacology 43:21\u201333","journal-title":"Neuropsychopharmacology"},{"key":"597_CR163","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10753-020-01271-4","volume":"43","author":"T Minamihata","year":"2020","unstructured":"Minamihata T, Takano K, Moriyama M, Nakamura Y (2020) Lysophosphatidylinositol, an endogenous ligand for G protein-coupled receptor 55, has anti-inflammatory effects in cultured microglia. Inflammation 43:1971\u20131987","journal-title":"Inflammation"},{"key":"597_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2023.106295","volume":"154","author":"HD Mir","year":"2023","unstructured":"Mir HD, Giorgini G, Di Marzo V (2023) The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders. Psychoneuroendocrinology 154:106295","journal-title":"Psychoneuroendocrinology"},{"key":"597_CR165","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1523\/JNEUROSCI.23-16-06470.2003","volume":"23","author":"F Molina-Holgado","year":"2003","unstructured":"Molina-Holgado F, Pinteaux E, Moore JD, Molina-Holgado E, Guaza C, Gibson RM et al (2003) Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J Neurosci 23:6470\u20136474","journal-title":"J Neurosci"},{"key":"597_CR166","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1124\/jpet.110.169359","volume":"335","author":"NL Moore","year":"2010","unstructured":"Moore NL, Greenleaf AL, Acheson SK, Wilson WA, Swartzwelder HS, Kuhn CM (2010) Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats. J Pharmacol Exp Ther 335:294\u2013301","journal-title":"J Pharmacol Exp Ther"},{"key":"597_CR167","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JHD-130050","volume":"2","author":"AJ Morton","year":"2013","unstructured":"Morton AJ, Howland DS (2013) Large genetic animal models of Huntington\u2019s disease. J Huntingtons Dis 2:3\u201319","journal-title":"J Huntingtons Dis"},{"key":"597_CR168","volume":"11","author":"Y Mu","year":"2024","unstructured":"Mu Y, Chang KX, Chen YF, Yan K, Wang CX, Hua Q (2024) Diagnosis of Alzheimer\u2019s disease: towards accuracy and accessibility. J Biol Methods 11:e99010010","journal-title":"J Biol Methods"},{"key":"597_CR169","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2174\/1568026618666180330141351","volume":"18","author":"J Muhammad","year":"2018","unstructured":"Muhammad J, Khan A, Ali A, Fang L, Yanjing W, Xu Q et al (2018) Network pharmacology: exploring the resources and methodologies. Curr Top Med Chem 18:949\u2013964","journal-title":"Curr Top Med Chem"},{"key":"597_CR170","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/13543784.2017.1270266","volume":"26","author":"T M\u00fcller","year":"2017","unstructured":"M\u00fcller T (2017) Investigational agents for the management of Huntington\u2019s disease. Expert Opin Investig Drugs 26:175\u2013185","journal-title":"Expert Opin Investig Drugs"},{"key":"597_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2009.02.001","volume":"201","author":"H Nakanishi","year":"2009","unstructured":"Nakanishi H, Wu Z (2009) Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging. Behav Brain Res 201:1\u20137","journal-title":"Behav Brain Res"},{"key":"597_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.718850","volume":"13","author":"P Nidadavolu","year":"2021","unstructured":"Nidadavolu P, Bilkei-Gorzo A, Kr\u00e4mer M, Sch\u00fcrmann B, Palmisano M, Beins EC et al (2021) Efficacy of \u03949-tetrahydrocannabinol (THC) alone or in combination with a 1:1 ratio of cannabidiol (CBD) in reversing the spatial learning deficits in old mice. Front Aging Neurosci 13:718850","journal-title":"Front Aging Neurosci"},{"key":"597_CR173","doi-asserted-by":"publisher","first-page":"10254","DOI":"10.3390\/ijms231810254","volume":"23","author":"P Nidadavolu","year":"2022","unstructured":"Nidadavolu P, Bilkei-Gorzo A, Effah F, Leidmaa E, Sch\u00fcrmann B, Berger M et al (2022) Dynamic changes in the endocannabinoid system during the aging process: focus on the middle-age crisis. Int J Mol Sci 23:10254","journal-title":"Int J Mol Sci"},{"key":"597_CR174","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/glia.24256","volume":"71","author":"JA Noriega-Prieto","year":"2023","unstructured":"Noriega-Prieto JA, Kofuji P, Araque A (2023) Endocannabinoid signaling in synaptic function. Glia 71:36\u201343","journal-title":"Glia"},{"key":"597_CR175","volume-title":"Health at a glance","author":"OECD","year":"2017","unstructured":"OECD (2017) Health at a glance. OECD"},{"key":"597_CR176","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1073\/pnas.0504187103","volume":"103","author":"O Ofek","year":"2006","unstructured":"Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K et al (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103:696\u2013701","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR177","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.expneurol.2017.06.018","volume":"298","author":"CW Olanow","year":"2017","unstructured":"Olanow CW, Kieburtz K, Katz R (2017) Clinical approaches to the development of a neuroprotective therapy for PD. Exp Neurol 298:246\u2013251","journal-title":"Exp Neurol"},{"key":"597_CR178","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13195-024-01456-1","volume":"16","author":"M Oosthoek","year":"2024","unstructured":"Oosthoek M, Vermunt L, de Wilde A, Bongers B, Antwi-Berko D, Scheltens P et al (2024) Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer\u2019s disease: a systematic review. Alzheimers Res Ther 16:93","journal-title":"Alzheimers Res Ther"},{"key":"597_CR179","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1523\/JNEUROSCI.5483-10.2011","volume":"31","author":"MJ Oudin","year":"2011","unstructured":"Oudin MJ, Gajendra S, Williams G, Hobbs C, Lalli G, Doherty P (2011) Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain. J Neurosci 31:4000\u20134011","journal-title":"J Neurosci"},{"key":"597_CR180","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","volume":"50","author":"P Pacher","year":"2011","unstructured":"Pacher P, Mechoulam R (2011) Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 50:193\u2013211","journal-title":"Prog Lipid Res"},{"key":"597_CR181","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1096\/fj.06-6164fje","volume":"20","author":"J Palazuelos","year":"2006","unstructured":"Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzm\u00e1n M, Galve-Roperh I (2006) Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J 20:2405\u20132407","journal-title":"FASEB J"},{"key":"597_CR1001","doi-asserted-by":"crossref","unstructured":"Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, Sagredo O, Benito C, Romero J, Azcoitia I, Fern\u00e1ndez-Ruiz J, Guzm\u00e1n M, Galve-Roperh I (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity. Brain 132:3152\u20133164","DOI":"10.1093\/brain\/awp239"},{"key":"597_CR182","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2174\/1389450110607011539","volume":"7","author":"A Paradisi","year":"2006","unstructured":"Paradisi A, Oddi S, Maccarrone M (2006) The endocannabinoid system in ageing: a new target for drug development. Curr Drug Targets 7:1539\u20131552","journal-title":"Curr Drug Targets"},{"key":"597_CR183","doi-asserted-by":"publisher","first-page":"S365","DOI":"10.33549\/physiolres.935229","volume":"72","author":"A Pa\u0159\u00edzek","year":"2023","unstructured":"Pa\u0159\u00edzek A, Suchop\u00e1r J, La\u0161t\u016fvka Z, Alblov\u00e1 M, Hill M, Du\u0161kov\u00e1 M (2023) The endocannabinoid system and its relationship to human reproduction. Physiol Res 72:S365\u2013S380","journal-title":"Physiol Res"},{"key":"597_CR184","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41422-024-00971-y","volume":"34","author":"TY Park","year":"2024","unstructured":"Park TY, Jeon J, Cha Y, Kim KS (2024) Past, present, and future of cell replacement therapy for parkinson\u2019s disease: a novel emphasis on host immune responses. Cell Res 34:479\u2013492","journal-title":"Cell Res"},{"key":"597_CR185","doi-asserted-by":"publisher","first-page":"1306312","DOI":"10.3389\/fnagi.2024.1306312","volume":"16","author":"JB P\u00e9rot","year":"2024","unstructured":"P\u00e9rot JB, Brouillet E, Flament J (2024) The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington\u2019s disease. Front Aging Neurosci 16:1306312","journal-title":"Front Aging Neurosci"},{"key":"597_CR186","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","volume":"9","author":"D Petrov","year":"2017","unstructured":"Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci 9:68","journal-title":"Front Aging Neurosci"},{"key":"597_CR187","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.mad.2013.08.001","volume":"134","author":"A Piyanova","year":"2013","unstructured":"Piyanova A, Albayram O, Rossi CA, Farwanah H, Michel K, Nicotera P et al (2013) Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus. Mech Ageing Dev 134:391\u2013399","journal-title":"Mech Ageing Dev"},{"key":"597_CR188","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mad.2015.08.005","volume":"150","author":"A Piyanova","year":"2015","unstructured":"Piyanova A, Lomazzo E, Bindila L, Lerner R, Albayram O, Ruhl T et al (2015) Age-related changes in the endocannabinoid system in the mouse hippocampus. Mech Ageing Dev 150:55\u201364","journal-title":"Mech Ageing Dev"},{"key":"597_CR189","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.irn.2020.03.022","volume":"154","author":"G Plascencia-Villa","year":"2020","unstructured":"Plascencia-Villa G, Perry G (2020) Status and future directions of clinical trials in Alzheimer\u2019s disease. Int Rev Neurobiol 154:3\u201350","journal-title":"Int Rev Neurobiol"},{"key":"597_CR190","first-page":"494","volume":"1","author":"E Pop","year":"2000","unstructured":"Pop E (2000) Dexanabinol Pharmos. Curr Opin Investig Drugs 1:494\u2013503","journal-title":"Curr Opin Investig Drugs"},{"key":"597_CR191","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209394","volume":"102","author":"RN Rees","year":"2024","unstructured":"Rees RN, Noyce AJ, Schrag AE (2024) Identification of prodromal Parkinson disease: we may be able to but should we? Neurology 102:e209394","journal-title":"Neurology"},{"key":"597_CR192","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-024-00402-3","volume":"13","author":"C Rim","year":"2024","unstructured":"Rim C, You MJ, Nahm M, Kwon MS (2024) Emerging role of senescent microglia in brain aging-related neurodegenerative diseases. Transl Neurodegener 13:10","journal-title":"Transl Neurodegener"},{"key":"597_CR193","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fphar.2016.00221","volume":"7","author":"EM Rock","year":"2016","unstructured":"Rock EM, Parker LA (2016) Cannabinoids as potential treatment for chemotherapy-induced nausea and vomiting. Front Pharmacol 7:221","journal-title":"Front Pharmacol"},{"key":"597_CR194","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JHD-189001","volume":"7","author":"FB Rodrigues","year":"2018","unstructured":"Rodrigues FB, Wild EJ (2018) Huntington\u2019s disease clinical trials corner: February 2018. J Huntingtons Dis 7:89\u201398","journal-title":"J Huntingtons Dis"},{"key":"597_CR195","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/bph.15386","volume":"178","author":"C Rodr\u00edguez-Cueto","year":"2021","unstructured":"Rodr\u00edguez-Cueto C, Garc\u00eda-Toscano L, Santos-Garc\u00eda I, G\u00f3mez-Almer\u00eda M, Gonzalo-Consuegra C, Espejo-Porras F et al (2021a) Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis. Br J Pharmacol 178:1373\u20131387","journal-title":"Br J Pharmacol"},{"key":"597_CR196","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12972","volume":"31","author":"C Rodr\u00edguez-Cueto","year":"2021","unstructured":"Rodr\u00edguez-Cueto C, G\u00f3mez-Almer\u00eda M, Garc\u00eda Toscano L, Romero J, Hillard CJ, de Lago E et al (2021b) Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP-43 transgenic mice, a model of amyotrophic lateral sclerosis. Brain Pathol 31:e12972","journal-title":"Brain Pathol"},{"key":"597_CR197","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00001756-199302000-00005","volume":"4","author":"F Rodr\u00edguez de Fonseca","year":"1993","unstructured":"Rodr\u00edguez de Fonseca F, Ramos JA, Bonnin A, Fern\u00e1ndez-Ruiz J (1993) Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport 4:135\u2013138","journal-title":"Neuroreport"},{"key":"597_CR198","doi-asserted-by":"publisher","first-page":"S515","DOI":"10.3233\/JAD-141479","volume":"42","author":"O Rodr\u00edguez-G\u00f3mez","year":"2014","unstructured":"Rodr\u00edguez-G\u00f3mez O, Palacio-Lacambra ME, Palas\u00ed A, Ruiz-Laza A, Boada-Rovira M (2014) Prevention of Alzheimer\u2019s disease: a global challenge for next generation neuroscientists. J Alzheimers Dis 42:S515\u2013S523","journal-title":"J Alzheimers Dis"},{"key":"597_CR199","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/(SICI)1098-2396(199707)26:3<317::AID-SYN12>3.0.CO;2-S","volume":"26","author":"J Romero","year":"1997","unstructured":"Romero J, Garc\u00eda-Palomero E, Berrendero F, Garc\u00eda-Gil L, Hern\u00e1ndez ML, Ramos JA et al (1997) Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26:317\u2013323","journal-title":"Synapse"},{"key":"597_CR200","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0306-4522(97)00552-6","volume":"84","author":"J Romero","year":"1998","unstructured":"Romero J, Berrendero F, Garcia-Gil L, de la Cruz P, Ramos JA, Fern\u00e1ndez-Ruiz J (1998) Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5\u2019O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience 84:1075\u20131083","journal-title":"Neuroscience"},{"key":"597_CR201","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/mds.26026","volume":"29","author":"A Rosser","year":"2014","unstructured":"Rosser A, Svendsen CN (2014) Stem cells for cell replacement therapy: a therapeutic strategy for HD? Mov Disord 29:1446\u20131454","journal-title":"Mov Disord"},{"key":"597_CR202","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1096\/fj.07-102731","volume":"22","author":"R Rozenfeld","year":"2008","unstructured":"Rozenfeld R, Devi LA (2008) Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J 22:2311\u20132322","journal-title":"FASEB J"},{"key":"597_CR203","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199671618.001.0001","volume-title":"Imaging neurodegenerative disorders","author":"L Saba","year":"2015","unstructured":"Saba L (2015) Imaging neurodegenerative disorders. Oxford University Press"},{"key":"597_CR1000","doi-asserted-by":"crossref","unstructured":"Sagredo O, Gonz\u00e1lez S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, Romero JP, Tol\u00f3n RM, Mechoulam R, Brouillet E, Romero J, Fern\u00e1ndez-Ruiz J (2009) Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington\u2019s disease. Glia 57:1154\u20131167","DOI":"10.1002\/glia.20838"},{"key":"597_CR204","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bcp.2018.08.014","volume":"157","author":"O Sagredo","year":"2018","unstructured":"Sagredo O, Palazuelos J, Gutierrez-Rodriguez A, Satta V, Galve-Roperh I, Mart\u00ednez-Orgado J (2018) Cannabinoid signalling in the immature brain: encephalopathies and neurodevelopmental disorders. Biochem Pharmacol 157:85\u201396","journal-title":"Biochem Pharmacol"},{"key":"597_CR205","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/brain.2011.0056","volume":"1","author":"DH Salat","year":"2011","unstructured":"Salat DH (2011) The declining infrastructure of the aging brain. Brain Connect 1:279\u2013293","journal-title":"Brain Connect"},{"key":"597_CR206","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.3390\/ijms22179608","volume":"22","author":"AB Salmina","year":"2021","unstructured":"Salmina AB, Kapkaeva MR, Vetchinova AS, Illarioshkin SN (2021) Novel approaches used to examine and control neurogenesis in Parkinson\u2019s disease. Int J Mol Sci 22:9608","journal-title":"Int J Mol Sci"},{"key":"597_CR207","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/mds.26021","volume":"29","author":"C Sampaio","year":"2014","unstructured":"Sampaio C, Borowsky B, Reilmann R (2014) Clinical trials in Huntington\u2019s disease: interventions in early clinical development and newer methodological approaches. Mov Disord 29:1419\u20131428","journal-title":"Mov Disord"},{"key":"597_CR208","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awae035","volume":"147","author":"P S\u00e1nchez-Juan","year":"2024","unstructured":"S\u00e1nchez-Juan P, Valeriano-Lorenzo E, Ruiz-Gonz\u00e1lez A, Pastor AB, Rodrigo Lara H, L\u00f3pez-Gonz\u00e1lez F et al (2024) Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain 147:1667\u20131679","journal-title":"Brain"},{"key":"597_CR209","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1042\/BST20130134","volume":"41","author":"S Sarkar","year":"2013","unstructured":"Sarkar S (2013) Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. Biochem Soc Trans 41:1103\u20131130","journal-title":"Biochem Soc Trans"},{"key":"597_CR210","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B et al (2017) APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J 36:2473\u20132487","journal-title":"EMBO J"},{"key":"597_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105743","volume":"169","author":"SY Shen","year":"2022","unstructured":"Shen SY, Yu R, Li W, Liang LF, Han QQ, Huang HJ et al (2022) The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice. Neurobiol Dis 169:105743","journal-title":"Neurobiol Dis"},{"key":"597_CR212","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.870517","volume":"14","author":"M Shi","year":"2022","unstructured":"Shi M, Chu F, Zhu F, Zhu J (2022) Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab. Front Aging Neurosci 14:870517","journal-title":"Front Aging Neurosci"},{"key":"597_CR213","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/neu.1993.10.109","volume":"10","author":"E Shohami","year":"1993","unstructured":"Shohami E, Novikov M, Mechoulam R (1993) A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. J Neurotrauma 10:109\u2013119","journal-title":"J Neurotrauma"},{"key":"597_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.646924","volume":"13","author":"E Sikora","year":"2021","unstructured":"Sikora E, Bielak-Zmijewska A, Dudkowska M, Krzystyniak A, Mosieniak G, Wesierska M et al (2021) Cellular senescence in brain aging. Front Aging Neurosci 13:646924","journal-title":"Front Aging Neurosci"},{"key":"597_CR215","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.neuroscience.2004.09.040","volume":"130","author":"G Simic","year":"2005","unstructured":"Simic G, Bexheti S, Kelovic Z, Kos M, Grbic K, Hof PR et al (2005) Hemispheric asymmetry, modular variability and age-related changes in the human entorhinal cortex. Neuroscience 130:911\u2013925","journal-title":"Neuroscience"},{"key":"597_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110438","volume":"113","author":"JJ Simone","year":"2022","unstructured":"Simone JJ, Green MR, McCormick CM (2022) Endocannabinoid system contributions to sex-specific adolescent neurodevelopment. Prog Neuro-Psychopharmacol Biol Psychiatry 113:110438","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"597_CR217","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrn3085","volume":"12","author":"SA Small","year":"2011","unstructured":"Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA (2011) A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 12:585\u2013601","journal-title":"Nat Rev Neurosci"},{"key":"597_CR218","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/glia.20983","volume":"58","author":"N Stella","year":"2010","unstructured":"Stella N (2010) Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58:1017\u20131030","journal-title":"Glia"},{"key":"597_CR219","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/1673-5374.202935","volume":"12","author":"TB Stoker","year":"2017","unstructured":"Stoker TB, Blair NF, Barker RA (2017) Neural grafting for Parkinson\u2019s disease: challenges and prospects. Neural Regen Res 12:389\u2013392","journal-title":"Neural Regen Res"},{"key":"597_CR220","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrn3151","volume":"13","author":"AM Stranahan","year":"2012","unstructured":"Stranahan AM, Mattson MP (2012) Recruiting adaptive cellular stress responses for successful brain ageing. Nat Rev Neurosci 13:209\u2013216","journal-title":"Nat Rev Neurosci"},{"key":"597_CR221","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresrev.2008.07.007","volume":"59","author":"L Tapia-Arancibia","year":"2008","unstructured":"Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (2008) New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 59:201\u2013220","journal-title":"Brain Res Rev"},{"key":"597_CR222","doi-asserted-by":"publisher","first-page":"1259012","DOI":"10.3389\/fnagi.2023.1259012","volume":"15","author":"NS Tobeh","year":"2023","unstructured":"Tobeh NS, Bruce KD (2023) Emerging Alzheimer\u2019s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions. Front Aging Neurosci 15:1259012","journal-title":"Front Aging Neurosci"},{"key":"597_CR223","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/bcpt.14042","volume":"135","author":"RK Tuominen","year":"2024","unstructured":"Tuominen RK, Renko JM (2024) Biomarkers of Parkinson\u2019s disease in perspective of early diagnosis and translation of neurotrophic therapies. Basic Clin Pharmacol Toxicol 135:271","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"597_CR224","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejphar.2008.01.058","volume":"585","author":"V Trezza","year":"2008","unstructured":"Trezza V, Cuomo V, Vanderschuren LJ (2008) Cannabis and the developing brain: insights from behavior. Eur J Pharmacol 585:441\u2013452","journal-title":"Eur J Pharmacol"},{"key":"597_CR225","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/cns.13429","volume":"26","author":"M Ugrumov","year":"2020","unstructured":"Ugrumov M (2020) Development of early diagnosis of Parkinson\u2019s disease: illusion or reality? CNS Neurosci Ther 26:997\u20131009","journal-title":"CNS Neurosci Ther"},{"key":"597_CR226","doi-asserted-by":"publisher","DOI":"10.18356\/b793d926-en","volume-title":"World population prospects: the 2015 revision","author":"United Nations","year":"2015","unstructured":"United Nations (2015) World population prospects: the 2015 revision. UN"},{"key":"597_CR227","doi-asserted-by":"publisher","first-page":"6313","DOI":"10.3390\/molecules26206313","volume":"26","author":"A Valeri","year":"2021","unstructured":"Valeri A, Mazzon E (2021) Cannabinoids and neurogenesis: the promised solution for neurodegeneration? Molecules 26:6313","journal-title":"Molecules"},{"key":"597_CR228","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.neuroimage.2007.10.053","volume":"39","author":"K Van Laere","year":"2008","unstructured":"Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon J et al (2008) Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. NeuroImage 39:1533\u20131541","journal-title":"NeuroImage"},{"key":"597_CR229","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3390\/ijms22042110","volume":"22","author":"WM van Oostveen","year":"2021","unstructured":"van Oostveen WM, de Lange ECM (2021) Imaging techniques in Alzheimer\u2019s disease: a review of applications in early diagnosis and longitudinal monitoring. Int J Mol Sci 22:2110","journal-title":"Int J Mol Sci"},{"key":"597_CR230","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1471-4159.2009.06537.x","volume":"112","author":"R von Bernhardi","year":"2010","unstructured":"von Bernhardi R, Tichauer JE, Eugen\u00edn J (2010) Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem 112:1099\u20131114","journal-title":"J Neurochem"},{"key":"597_CR231","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2020.610484","volume":"14","author":"A Vega-Garc\u00eda","year":"2021","unstructured":"Vega-Garc\u00eda A, Feria-Romero I, Garc\u00eda-Ju\u00e1rez A, Munguia-Madera AC, Montes-Aparicio AV, Zequeida-Mu\u00f1oz E et al (2021) Cannabinoids: a new perspective on epileptogenesis and seizure treatment in early life in basic and clinical studies. Front Behav Neurosci 14:610484","journal-title":"Front Behav Neurosci"},{"key":"597_CR232","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12017-014-8314-x","volume":"16","author":"E Vendel","year":"2014","unstructured":"Vendel E, de Lange EC (2014) Functions of the CB1 and CB2 receptors in neuroprotection at the level of the blood-brain barrier. NeuroMolecular Med 16:620\u2013642","journal-title":"NeuroMolecular Med"},{"key":"597_CR233","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1073\/pnas.0336351100","volume":"100","author":"L Wang","year":"2003","unstructured":"Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100:1393\u20131398","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR234","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejmech.2019.02.076","volume":"169","author":"T Wang","year":"2019","unstructured":"Wang T, Liu XH, Guan J, Ge S, Wu MB, Lin JP et al (2019) Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer\u2019s disease. Eur J Med Chem 169:200\u2013223","journal-title":"Eur J Med Chem"},{"key":"597_CR235","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nutres.2019.06.003","volume":"70","author":"BA Watkins","year":"2019","unstructured":"Watkins BA (2019) Diet, endocannabinoids, and health. Nutr Res 70:32\u201339","journal-title":"Nutr Res"},{"key":"597_CR236","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0197-4580(93)90113-P","volume":"14","author":"MJ West","year":"1993","unstructured":"West MJ (1993) Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 14:287\u2013293","journal-title":"Neurobiol Aging"},{"key":"597_CR237","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/path.4648","volume":"238","author":"CB Whitelaw","year":"2016","unstructured":"Whitelaw CB, Sheets TP, Lillico SG, Telugu BP (2016) Engineering large animal models of human disease. J Pathol 238:247\u2013256","journal-title":"J Pathol"},{"key":"597_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108736","volume":"197","author":"BL Winters","year":"2021","unstructured":"Winters BL, Vaughan CW (2021) Mechanisms of endocannabinoid control of synaptic plasticity. Neuropharmacology 197:108736","journal-title":"Neuropharmacology"},{"key":"597_CR239","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-064169","volume":"13","author":"C Wong","year":"2023","unstructured":"Wong C, Gregory JM, Liao J, Egan K, Vesterinen HM, Ahmad Khan A et al (2023) Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus. BMJ Open 13:e064169","journal-title":"BMJ Open"},{"key":"597_CR240","volume-title":"Life expectancy increased by 5 years since 2000, but health inequalities persist","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) Life expectancy increased by 5 years since 2000, but health inequalities persist. WHO"},{"key":"597_CR241","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s40001-023-01512-w","volume":"28","author":"W Wu","year":"2023","unstructured":"Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F et al (2023) The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Med Res 28:544","journal-title":"Eur J Med Res"},{"key":"597_CR242","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3233\/JPD-230363","volume":"14","author":"RK Wyse","year":"2024","unstructured":"Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D et al (2024) Twelve years of drug prioritization to help accelerate disease modification trials in Parkinson\u2019s disease: the International Linked Clinical Trials Initiative. J Parkinsons Dis 14:657\u2013666","journal-title":"J Parkinsons Dis"},{"key":"597_CR243","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.793750","volume":"12","author":"Y Xin","year":"2022","unstructured":"Xin Y, Tang A, Pan S, Zhang J (2022) Components of the endocannabinoid system and effects of cannabinoids against bone diseases: a mini-review. Front Pharmacol 12:793750","journal-title":"Front Pharmacol"},{"key":"597_CR244","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnmol.2016.00030","volume":"9","author":"W Yang","year":"2016","unstructured":"Yang W, Tu Z, Sun Q, Li XJ (2016) CRISPR\/Cas9: implications for modeling and therapy of neurodegenerative diseases. Front Mol Neurosci 9:30","journal-title":"Front Mol Neurosci"},{"key":"597_CR245","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0083-6729(09)81002-9","volume":"81","author":"ML Yates","year":"2009","unstructured":"Yates ML, Barker EL (2009) Organized trafficking of anandamide and related lipids. Vitam Horm 81:25\u201353","journal-title":"Vitam Horm"},{"key":"597_CR246","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2377-6-12","volume":"6","author":"Y Yiangou","year":"2006","unstructured":"Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C et al (2006) COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6:12","journal-title":"BMC Neurol"},{"key":"597_CR247","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/0300985815623997","volume":"53","author":"SA Youssef","year":"2016","unstructured":"Youssef SA, Capucchio MT, Rofina JE, Chambers JK, Uchida K, Nakayama H et al (2016) Pathology of the aging brain in domestic and laboratory animals, and animal models of human neurodegenerative diseases. Vet Pathol 53:327\u2013348","journal-title":"Vet Pathol"},{"key":"597_CR248","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4103\/1673-5374.382224","volume":"19","author":"J Zhao","year":"2024","unstructured":"Zhao J, Liu S, Xiang X, Zhu X (2024) Versatile strategies for adult neurogenesis: avenues to repair the injured brain. Neural Regen Res 19:774\u2013780","journal-title":"Neural Regen Res"},{"key":"597_CR249","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","volume":"19","author":"MZ Zhong","year":"2024","unstructured":"Zhong MZ, Peng T, Duarte ML, Wang M, Cai D (2024) Updates on mouse models of Alzheimer\u2019s disease. Mol Neurodegener 19:23","journal-title":"Mol Neurodegener"},{"key":"597_CR250","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12993-021-00179-9","volume":"17","author":"A Zia","year":"2021","unstructured":"Zia A, Pourbagher-Shahri AM, Farkhondeh T, Samarghandian S (2021) Molecular and cellular pathways contributing to brain aging. Behav Brain Funct 17:6","journal-title":"Behav Brain Funct"},{"key":"597_CR251","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000522432","volume":"5","author":"W Zieglg\u00e4nsberger","year":"2022","unstructured":"Zieglg\u00e4nsberger W, Brenneisen R, Berthele A, Wotjak CT, Bandelow B, T\u00f6lle TR et al (2022) Chronic pain and the endocannabinoid system: smart lipids \u2013 a novel therapeutic option? Med Cannabis Cannabinoids 5:61\u201375","journal-title":"Med Cannabis Cannabinoids"},{"key":"597_CR252","doi-asserted-by":"publisher","first-page":"309","DOI":"10.55782\/ane-2012-1904","volume":"72","author":"M Ziemka-Na\u0142\u0119cz","year":"2012","unstructured":"Ziemka-Na\u0142\u0119cz M, Zalewska T (2012) Endogenous neurogenesis induced by ischemic brain injury or neurodegenerative diseases in adults. Acta Neurobiol Exp 72:309\u2013324","journal-title":"Acta Neurobiol Exp"},{"key":"597_CR253","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1111\/bph.12607","volume":"171","author":"S Zoppi","year":"2014","unstructured":"Zoppi S, Madrigal JL, Caso JR, Garc\u00eda-Guti\u00e9rrez MS, Manzanares J, Leza JC et al (2014) Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice. Br J Pharmacol 171:2814\u20132826","journal-title":"Br J Pharmacol"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Impact of Cannabinoids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2025_597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:01:44Z","timestamp":1777381304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2025_597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783032091321","9783032091338"],"references-count":255,"URL":"https:\/\/doi.org\/10.1007\/7854_2025_597","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"25 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}